西安瑞联新材料股份有限公司2025 年半年度报告 公司代码：688550 公司简称：瑞联新材 西安瑞联新材料股份有限公司 西安瑞联新材料股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险，敬请查阅本报告第三节 "管理层讨论与分析"中"四、风险因素"部分。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人刘晓春、主管会计工作负责人王银彬及会计机构负责人（会计主管人员）陈涛 声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本半年度报告中所涉及的未来计划、发展战略等前瞻性描述，不构成公司对投资者的实质承 诺，敬请投资者注意投资风险。 九、 是否存在被控股股东及其他关联方非经营性占用 ...

Core Viewpoint - Both TCL Technology and Ruile New Materials expect their performance to rise in the first half of 2025, with significant growth in net profits and revenues [1][2][7]. TCL Technology - For the first half of 2025, TCL Technology anticipates revenue between 82.6 billion and 90.6 billion yuan, representing a year-on-year growth of 3% to 13% [2]. - The net profit attributable to shareholders is expected to be between 1.8 billion and 2 billion yuan, showing a year-on-year increase of 81% to 101% [2]. - The net profit after excluding non-recurring gains and losses is projected to be between 1.5 billion and 1.65 billion yuan, reflecting a growth of 168% to 195% [2]. - The semiconductor display business is expected to achieve a net profit exceeding 4.6 billion yuan, with a year-on-year increase of over 70% [3]. - The company is focusing on optimizing its display business layout and product structure to enhance competitive advantages and profitability [5]. - The acquisition of a 21.5311% stake in Shenzhen Huaxing Optoelectronics Semiconductor Display Technology Co., Ltd. was completed on July 1, 2025, further strengthening the company's competitive position [6]. - In the solar energy sector, TCL Technology anticipates challenges due to price declines and inventory impairments, projecting a net profit loss of 1.2 billion to 1.35 billion yuan for the first half of 2025 [6]. Ruile New Materials - Ruile New Materials expects to achieve an operating income of 806 million yuan in the first half of 2025, a year-on-year increase of 16.27% [7]. - The net profit attributable to shareholders is projected to be 162 million yuan, reflecting a year-on-year growth of 69.93% [7]. - The net profit after excluding non-recurring gains and losses is expected to be 157 million yuan, with a year-on-year increase of 80.12% [7]. - The significant growth in the pharmaceutical sector's revenue and improved product structure have contributed to the overall increase in gross margin [7].

Core Viewpoint - The battle for control over Ruian New Materials has intensified, showcasing a classic case of power struggle between state-owned enterprises and original shareholders following the implementation of the new Company Law in China [1][2][10]. Group 1: Control Rights and Governance Structure - The proposal to abolish the supervisory board was aimed at streamlining governance in response to the 2023 Company Law reforms, allowing the audit committee to take over its functions [4][10]. - The proposal was rejected at the annual shareholders' meeting on May 12, 2025, with 43.84% in favor and 54.97% against, indicating strong opposition from the original shareholders [6][10]. - The rejection of the supervisory board abolition reflects the fierce confrontation between the state-owned enterprise and the original shareholders, as it would have weakened the latter's influence in corporate governance [10][22]. Group 2: Shareholder Dynamics and Financial Performance - Following the expiration of the original concerted action agreement in September 2023, Ruian New Materials entered a "leaderless" state, with original shareholders holding approximately 37% of the shares [13][14]. - In 2024, the company reported a total revenue of 1.459 billion yuan, a year-on-year increase of 20.74%, and a net profit of 252 million yuan, up 87.60%, reversing the downward trend from the second half of 2022 [16]. - The stock price of Ruian New Materials experienced significant volatility, rising 13.3% after a judicial ruling in March 2025 but falling back to around 39 yuan following the rejection of the supervisory board proposal, resulting in a market value decline of over 20% from its peak [10][11]. Group 3: Strategic Implications and Future Outlook - The entry of the state-owned enterprise is driven by the strategic goal of completing the display materials industry chain, which includes trade, engineering, and shipbuilding [14][16]. - The ongoing conflict over control rights not only highlights the challenges of state-owned enterprises acquiring private companies but also raises concerns about potential adjustments in technology direction and governance structures [22][23]. - The original shareholders, led by Liu Xiaochun, are actively defending their operational control and have increased their shareholding to 15% through concerted actions, indicating a robust resistance against the state-owned enterprise's influence [18][19].

据了解，瑞联新材成立于1999年，注册地址位于陕西省西安市，于2020年9月在上交所科创板上市。公司主营业务为专用有机新材料的研发、生产 和销售，主要产品包括OLED材料、单体液晶、创新药中间体等，广泛应用于显示材料、医药产品和电子化学品等领域。 其中，在液晶材料方面，瑞联新材主要以单体液晶为主，终端客户覆盖全球六大混晶厂商Merck、JNC、DIC、江苏和成、诚志永华和八亿时空。 【WitsView整理】 3月20日，瑞联新材发布公告称，青岛开发区投资建设集团有限公司（以下简称"开投集团"）正式完成对公司的股权划转及表决 权委托程序，合计持有23.37%表决权。 与此同时，开投集团与海南卓世恒立创业投资合伙企业（有限合伙）签署的《表决权委托协议》及补充协议也将正式生效。根据协议内容，开投集 团将合并持有瑞联新材23.37%的表决权，从而成为拥有公司表决权股份的第一大股东。 在OLED材料方面，瑞联新材以OLED升华前材料为主，客户群已基本实现对国际领先的OLED终端材料企业的全覆盖，公司生产的OLED升华前材 料已实现对发光层材料、通用层材料等主要OLED终端材料的全覆盖。 自上市以来，瑞联新材的业绩相对稳 ...